Achaogen IncLatest Achaogen Inc News and UpdatesCompany & Industry OverviewsAnalysts’ Ratings for Spark Therapeutics and Its Peers in April 2018Of the 20 analysts covering Spark Therapeutics in April 2018, four have given the stock “strong buy” recommendations.
Company & Industry OverviewsAnalysts’ Ratings for Spark Therapeutics and Its Peers in April 2018Of the 20 analysts covering Spark Therapeutics in April 2018, four have given the stock “strong buy” recommendations.
